Development of DAS181 (Fludase^) as a Broad Spectrum Therapeutic Agent

Information

• Research Project
• 8020431

• ApplicationId

  8020431

• Core Project Number

  N01AI60015-5-0-1

• Full Project Number

  N01AI60015-5-0-1

• Serial Number

  0

• FOA Number

• Sub Project Id

• Project Start Date

  9/29/2006 - 18 years ago

• Project End Date

  9/28/2011 - 13 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2010

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• NEXBIO CO., LTD.

This contract supports the preclinical, nonclinical, and clinical development (phase I and phase II) of Fludase as a broad spectrum therapeutic agent for all annual and pandemic variations of influenza.

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  9999165

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:9999165\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  NEXBIO, INC.

• Organization Department

• Organization DUNS

  140600268

• Organization City

  SAN DIEGO

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  921211609

• Organization District

  UNITED STATES